T0	Outcomes 0 6	Safety
T1	Outcomes 11 37	preliminary immunogenicity
T2	Outcomes 489 499	the safety
T3	Outcomes 513 531	the immunogenicity
T4	Outcomes 653 667	well tolerated
T5	Outcomes 672 679	as safe
T6	Outcomes 822 865	significant increase of IgG GMC and OPA GMT